Kyung-Eun Lee Selected Research

Indicators and Reagents (Reagents)

2/2016

Myeloid cell leukemia-1 is a molecular indicator for malignant transformation of oral lichen planus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung-Eun Lee Research Topics

Disease

6	Neoplasms (Cancer) 04/2022 - 09/2010
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2019 - 05/2017
4	Ischemic Stroke 01/2018 - 12/2009
3	Mouth Neoplasms (Oral Cancer) 12/2017 - 03/2013
3	Rheumatoid Arthritis 12/2017 - 09/2014
2	Chronic Renal Insufficiency 05/2019 - 02/2015
2	Lupus Nephritis 01/2019 - 02/2018
2	Inflammation (Inflammations) 01/2019 - 03/2013
2	Sclerosis 04/2018 - 02/2018
2	Cicatrix (Scar) 02/2015 - 05/2012
2	Ankylosing Spondylitis 01/2015 - 09/2014
2	Ankylosis 01/2015 - 09/2014
2	Wounds and Injuries (Trauma) 05/2013 - 05/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2004 - 11/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022
1	Neutropenia 04/2022
1	Dihydropyrimidine Dehydrogenase Deficiency 02/2022
1	Ductal Carcinoma 01/2022
1	Hypertension (High Blood Pressure) 10/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021
1	Deglutition Disorders (Dysphagia) 10/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 09/2018
1	Osteoarthritis 04/2018
1	Atrophy 02/2018
1	Fibrosis (Cirrhosis) 02/2018
1	Pain (Aches) 12/2017
1	Acne Vulgaris 10/2017
1	Fibromyalgia (Fibrositis) 05/2017
1	Chronic Pain 05/2017
1	Neoplastic Cell Transformation 02/2016
1	Oral Lichen Planus 02/2016
1	Osteoporosis 01/2016
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 09/2015
1	Triple Negative Breast Neoplasms 04/2015
1	Breast Neoplasms (Breast Cancer) 04/2015
1	Carcinogenesis 04/2015
1	Gout 02/2015
1	Brain Edema (Cerebral Edema) 01/2015

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2008
3	AntibodiesIBA 05/2019 - 09/2015
3	Pharmaceutical PreparationsIBA 12/2017 - 03/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2004 - 11/2003
2	Histones (Histone)IBA 09/2018 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 07/2013
2	ametantrone (HAQ)IBA 12/2017 - 12/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 09/2014
2	Etoposide (VP 16)FDA LinkGeneric 12/2003 - 11/2003
1	ORALIT (ORS)IBA 04/2022
1	PlatinumIBA 04/2022
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 02/2022
1	human ERBB2 proteinIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Opioid Analgesics (Opioids)IBA 10/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 09/2021
1	CreatinineIBA 05/2019
1	CosmeceuticalsIBA 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	2'-fucosyllactoseIBA 01/2019
1	Particulate MatterIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	theasinensin AIBA 09/2018
1	trichostatin A (A 300)IBA 09/2018
1	Anticardiolipin AntibodiesIBA 07/2018
1	C-Reactive ProteinIBA 04/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2018
1	metal transporting protein 1 (ferroportin)IBA 01/2018
1	Ferritins (Ferritin)IBA 01/2018
1	HepcidinsIBA 01/2018
1	IronIBA 01/2018
1	DiterpenesIBA 12/2017
1	oridoninIBA 12/2017
1	Angiogenesis InhibitorsIBA 12/2017
1	Biological ProductsIBA 12/2017
1	PolyphenolsIBA 10/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2017
1	Sorafenib (BAY 43-9006)FDA Link 02/2016
1	mithramycin AIBA 02/2016
1	AgarIBA 02/2016
1	Indicators and Reagents (Reagents)IBA 02/2016
1	Trypan Blue FDA Link 02/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	GlucocorticoidsIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2015
1	PhosphoproteinsIBA 04/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2015
1	Allopurinol (Remid)FDA LinkGeneric 02/2015
1	Adalimumab (Humira)FDA Link 01/2015
1	CytokinesIBA 01/2015

Therapy/Procedure

6	Therapeutics 01/2019 - 11/2003
2	Neoadjuvant Therapy 11/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 04/2022 - 10/2004
2	Hematopoietic Stem Cell Transplantation 02/2004 - 02/2004
1	Cystectomy 11/2022
1	Adjuvant Chemotherapy 11/2022
1	Long-Term Care 10/2019